Company Filing History:
Years Active: 2021-2023
Title: Innovations of Matthew Elmes
Introduction
Matthew Elmes is an accomplished inventor based in Stony Brook, NY. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific proteins.
Latest Patents
Matthew Elmes holds two patents, with his latest inventions focusing on Alpha-truxillic acid derivatives and pharmaceutical compositions thereof. These patents provide a method for inhibiting the activity of a Fatty Acid Binding Protein (FABP) by contacting the FABP with a compound that has a specific structure.
Career Highlights
Matthew is affiliated with the State University of New York, where he conducts research and develops innovative solutions in the pharmaceutical domain. His work has implications for various therapeutic applications.
Collaborations
He has collaborated with notable colleagues, including Iwao Ojima and Dale Deutsch, to advance research in his field.
Conclusion
Matthew Elmes is a notable inventor whose work in pharmaceutical innovations continues to impact the scientific community. His contributions to the development of targeted compounds demonstrate his commitment to advancing healthcare solutions.